Financial News
Latest News about KTTA
Recent news which mentions KTTA
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 28, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 22, 2022
From Benzinga
From Benzinga
Pasithea' Largest Investor Group Says AlloMek Therapeutics Deal Ill-timed, Highly Dilutive
October 14, 2022
Tickers
KTTA
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 12, 2022
From Benzinga
EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition
October 12, 2022
Tickers
KTTA
From Benzinga
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope
October 10, 2022
From Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 31, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 30, 2022
From Benzinga
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox
August 11, 2022
Tickers
KTTA
From Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 02, 2022
From Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
From Benzinga
From Benzinga
From Benzinga
Pasithea's Latest Drug Candidate Could Bring New Hope To ALS Patients Without Effective Treatment Options
July 20, 2022
From Benzinga
Pasithea Therapeutics Receives AUD $1 Million Research Award Following Recent Acquisition
July 18, 2022
Tickers
KTTA
From Benzinga
This Biotech Company Says That It's Looking To Deliver A Breakthrough In Psychiatric Medicine — What's The Scoop?
June 27, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 17, 2022
From Benzinga
Pasithea Biotech Reports That It's Aiming To Be At The Forefront Of The Mental Health Revolution
April 25, 2022
From Benzinga
Virtual Reality Technologies Are Reportedly Unlocking New Possibilities For Mental Healthcare
April 18, 2022
From Benzinga
Pasithea Reveals Cash Position Of $52.9 Million In Latest Earnings Report, To Expand Pipeline And Fund Operations Well Into 2024
April 01, 2022
Tickers
KTTA
From Benzinga
This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction
March 24, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 15, 2022
From Benzinga
Pasithea Partners With Glimpse Group To Co-Develop VR Environments For Patients With Psychiatric Disorders
March 10, 2022
From Benzinga
EXCLUSIVE: Glimpse-Pasithea To Co-Develop VR Environments For Patients With Psychiatric Disorders
March 08, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
